While the biggest driver of growth for Amazon (NASDAQ: AMZN) has been coming from its cloud computing division, Amazon Web Services (AWS), the company is not just sitting still when it comes to other areas...
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.66%. Stocks retreated...
Analysts noted that this is Amazon’s “next iteration” of its Amazon Clinic service, which originally launched in 2022, but with Amazon-affiliated doctors and more attractive pricing compared to Hims....
Canada's main stock index touched a record high on Thursday, helped by energy stocks, while investors ...
The healthcare company is on fire, and it's still cheap by many measures.
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential
Hims & Hers strong performance involves much more than just GLP-1 drugs.
The company expects to enjoy many GLP-1 tailwinds in 2025.